Serum samples were obtained from patients with house dust mite–sensitive nasal allergies before and 6 months after immunotherapy, and the level of immunoglobulin (Ig)E, IgG1, and IgG4 antibodies in those sera was determined by the enzyme-linked immunosorbent assay. The present data showed that the mite-specific IgG4 antibodies increased in patients who responded well to immunotherapy but not in those who responded poorly. It was suggested from the present study that IgG4 antibodies seem to act as “blocking antibodies” to reduce the allergic reaction in the target organ, and that an increase of allergen-specific IgG4 antibodies following immunotherapy can be of clinical benefit to patients suffering from mite-specific nasal allergy.
OhashiYNakaiYKurokiK. Topical immunology of nasal allergy and mucosal IgE antibodies. Arch Otorhinolaryngol1985; 241: 169–74
2.
OhashiYNakaiYNakataJKiharaSIkeokaH. Nasal allergy and nasal polyp with special reference to the mucosal IgE antibodies. ORL J Otorhinolaryngol Relat Spec1986; 48: 233–7
3.
LichtensteinLMLevyDAIshizakaK. In vitro reversed anaphylaxis. Characteristics of anti-IgE-mediated histamine release. Immunology1971; 19: 831–42
4.
IshizakaTDeBernardoRTomiokaHLichtensteinLMIshizakaK. Identification of basophil granulocytes as a site of allergic histamine release. J Immunol1972; 108: 1000–8
5.
NakagawaTStadlerBMHeinerDCSkvarilFde WeekAL. Flow-cytometric analysis of human basophil degranulation. II. Degranulation induced by anti-IgE, anti-IgG4, and the calcium ionophore A23187. Clin Allergy1981; 11: 21–30
6.
NakagawaTde WeekAL. Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin Rev Allergy1983; 1: 197–206
7.
ParishWE. Short-term anaphylactic IgG antibodies in human sera. Lancet1970; 11: 951–2
8.
ParishWE. Evidence for human IgG antibodies anaphylactically sensitizing man; immediate hypersensitivity. Modern concepts and development. New York: Marcel Dekker, 1978: 277–99
9.
Van der GieesenMHomanWLvan KernbeekGAalberseRCDiegesPH. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch Allergy Appl Immunol1976; 50: 625–40
10.
DeveyMEWilsonDVWheelerAW. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization. Clin Allergy1976; 6: 227–36
11.
UrbanekMEForsterJKaritzkyDZiupaJ. The prognostic significance of specific IgG antibodies in insect sting allergy. Eur J Pediatr1981; 136: 31–4
12.
OkudaMSenbaO. Effects of beclomethasone dipropionate nasal spray on subjective and objective findings in perennial allergic rhinitis. Clin Otolaryngol1980; 5: 315–21
13.
OkudaMSakaguchiKOhtsukaH. Intranasal beclomethasone: Mode of action in nasal allergy. Ann Allergy1983; 50: 116–20
14.
OkudaMIshikawaTSaitoYShimizuTBabaS. A clinical evaluation of N′-5 with perennial-type allergic rhinitis. A test by multi-clinic, intergroup, doubleblind comparative method. Ann Allergy1984; 53: 178–85
15.
SkvarilFRoth-WickyBBarandunS. IgG subclasses in human-globulin preparations for intravenous use and their reactivity with Staphylococcus protein A. Vox Sangy1980; 38: 147–55
16.
NakagawaTTakaishiTMiyamotoTSugiMIshigeM. IgG4-enzyme-linked immunosorbent assay using an anti-human IgG4 monoclonal antibody. Jpn J Allergol1985; 34: 277–83
17.
EngvallEPerlmannP. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzymelabeled anti-immunoglobulin in antigen-coated tubes. J Immunol1972; 109: 129–35
18.
NoonL. Prophylactic inoculation against hay fever. Lancet1911; 1: 814–6
19.
FreemanJ. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet1911; 11: 814–5
20.
ZeigerRSSchatzM. Immunotherapy of atopic disorders. Med Clin North Am1981; 65: 987–1012
21.
VoorhorstRSpieksmaFTMVarekampHLeupenMJLyklemaAW. The house dust mite (Dermatophagoides pteronyssinus) and the allergens it produces. Identity with house dust allergen. J Allergy1967; 39: 325–39
22.
PepysJChanMHargreaveFE. Mites and house dust allergy. Lancet1968; 1: 1270–2
23.
MiyamotoTOshimaSIshizakaTSatoS. Allergenic identity between the common floor mite (Dermatophagoides farinae Hughes 1961) and house dust as a causative antigen in bronchial asthma. J Allergy1968; 42: 14–28
24.
NakagawaTKudoKOkudairaHMiyamotoTHoriuchiY. Characterization of the allergenic components of the house dust mite, Dermatophagoides farinae. Int Arch Allergy Appl Immunol1977; 55: 47–53
25.
SakamotoYNakagawaTItoKMiyamotoT. Solidphase radioimmunoassay for treatment of IgG antibodies specific for the house dust mite, Dermatophagoides farinae. Ann Allergy1984; 52: 303–8
26.
MiyamotoTAkiyamaKOhtaKUrataCHoriuchiY. Studies in atopic asthma with emphasis on correlation among various tests and various antibodies. J Allergy Clin Immunol1981; 67: 279–84
27.
StanworthDRSmithAK. Inhibition of reagin-mediated PCA reactions in baboons by the human IgG4 sub-class. Clin Allergy1973; 3: 37–41
28.
VijayHMPerelmutterL. Inhibition of reagin-mediated PCA reactions in monkeys and histamine release from human leukocytes by human IgG4 subclass. Int Arch Allergy Appl Immunol1977; 53: 78–87
29.
Van ToorenenbergenAWAalberseRC. IgG4 and passive sensitization of basophil leukocytes. Int Arch Allergy Appl Immunol1981; 65: 432–40
30.
GwynnCMAlmosawiTStanworthDR. Clinical association with serum allergen-specific IgG4 antibodies. Clin Allergy1982; 12: 459–64
31.
LeeTHDurhamSRMerrettJMerrettTGKayAB. Allergen-specific IgG4 in bronchial asthma. Lancet1982; 11: 1048–9
32.
NakagawaTTakaishiTSakamotoYMiyamotoTNakazawaTKobayashiS. Allergen-specific IgG4 antibodies and late asthmatic response. Jpn J Allergol1984; 33: 879–83
33.
OhashiYIkeokaHMaruokaKNakataJNakaiY. The pathology of nasal allergy with special reference to its surgical treatment. J Clin Electron Microsc1984; 17: 654–5
34.
OhashiYNakaiYKiharaSIkeokaHTakanoHImotoT. Ciliary activity in patients with nasal allergies. Arch Otorhinolaryngol1985; 242: 141–7
